Walter Rosebrough, Jr. Purchases 3,000 Shares of Cooper Companies (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) Director Walter Rosebrough, Jr. bought 3,000 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The stock was purchased at an average cost of $54.29 per share, for a total transaction of $162,870.00. Following the completion of the transaction, the director directly owned 20,000 shares in the company, valued at approximately $1,085,800. This trade represents a 17.65% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cooper Companies Price Performance

COO stock opened at $54.61 on Thursday. The stock has a 50-day moving average price of $70.58 and a two-hundred day moving average price of $68.98. The Cooper Companies, Inc. has a 12-month low of $51.01 and a 12-month high of $89.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The company has a market cap of $10.38 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 2.17 and a beta of 0.82.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the business posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.53 EPS for the current year.

Cooper Companies announced that its board has initiated a share buyback program on Wednesday, September 9th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the medical device company to buy up to 22.7% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Three directors collectively bought approximately $1.33 million of COO shares at prices around $53–$54, signaling that insiders may view the recent selloff as excessive or the stock as undervalued. Walter Rosebrough Jr. separately purchased 3,000 shares, bringing his reported total purchases to 10,000 shares. Insider buying report
• Positive Sentiment: Cooper Companies’ board authorized a $3 billion share-buyback program, potentially allowing repurchases of up to 22.7% of outstanding shares. The authorization may provide valuation support and suggests management believes the stock is attractively priced. Cooper Companies stock information
• Neutral Sentiment: COO’s latest quarter included adjusted EPS of $1.15, ahead of the $1.12 consensus, but revenue of approximately $1.07 billion missed expectations near $1.10 billion. Investors are focusing on whether weaker contact-lens demand and U.S. distributor inventory reductions are temporary. Cooper Companies earnings call summary
• Negative Sentiment: Analysts lowered the consensus price target by 14.83% to $72.27, reflecting reduced confidence after the revenue miss and outlook concerns. Consensus price target report
• Negative Sentiment: Cooper Companies cut fiscal 2026 guidance to adjusted EPS of $4.51–$4.55 and revenue of approximately $4.23–$4.25 billion. The reductions reflect slower contact-lens demand and ongoing U.S. channel inventory destocking, creating near-term earnings risk.
• Negative Sentiment: Multiple law firms, including Bragar Eagel & Squire, Levi & Korsinsky, Kirby McInerney and Rosen Law Firm, announced investigations into potential securities claims. These announcements do not establish wrongdoing, but they increase headline, litigation and investor-confidence risks. Bragar Eagel & Squire investigation

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. Citigroup reissued a “neutral” rating and issued a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday, September 10th. Mizuho set a $75.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, September 10th. Needham & Company LLC lowered their price target on Cooper Companies from $86.00 to $73.00 and set a “buy” rating for the company in a report on Thursday, September 10th. UBS Group cut their price objective on Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, September 10th. Finally, JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $71.00 to $58.00 and set a “neutral” rating on the stock in a research note on Thursday, September 10th. Five analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and an average price target of $71.47.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Cooper Companies during the 2nd quarter valued at $1,077,762,000. Generation Investment Management LLP acquired a new position in Cooper Companies in the 2nd quarter worth $356,304,000. Jupiter Topco LLC purchased a new position in Cooper Companies in the 2nd quarter valued at about $305,074,000. Franklin Resources Inc. boosted its position in Cooper Companies by 108.2% in the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after buying an additional 2,089,763 shares during the last quarter. Finally, JANA Partners Management LP grew its stake in shares of Cooper Companies by 0.5% during the second quarter. JANA Partners Management LP now owns 3,582,480 shares of the medical device company’s stock valued at $256,900,000 after acquiring an additional 17,322 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.